Protagonist Therapeutics

Protagonist Therapeutics: Proprietary peptide technology platform to develop oral targeted therapy-based drugs and injectables for rare diseases. PTG-300 injectable hepcidin mimetic Ph 2 trials ongoing in polycythemia vera and hereditary hemochromatosis; positive updated Ph 2 results in PV presented at ASH 2020. PN-943 oral GI-restricted alpha-4-beta-7 antagonist Ph 2 in ulcerative colitis study sites activated; PTG-200, partnered w/ Janssen, oral GI-restricted IL-23R antagonist Ph 2 Crohn’s disease study ongoing.
Based in...
US - Pacific
Clinical Stage
Phase l or ll
Disease Space
Anti-inflammatory, Autoimmune, Gastrointestinal, Rare Disease
Public, USA
Market Cap
1B +
Therapeutic Modalities
Platform Technology
521 Cottonwood Drive
Suite 100
Milpitas, CA 95035
United States

Company Participants at Protagonist Therapeutics Virtual KOL Event following ASH

  • Dinesh V Patel, PhD, President & CEO

Top 10 Holders of Protagonist Therapeutics, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Fidelity Management & Research Co. LLC 18.63 6,413,749 188.24 13F 12/31/20
BVF, Inc. 12.41 4,273,588 125.43 13F 12/31/20
BVF Partners LP 12.41 4,273,588 125.43 Stakes 12/31/20
RTW Investments LP 10.60 3,650,069 107.13 Stakes 12/31/20
Consonance Capital Management LP 7.93 2,729,709 80.12 13F 12/31/20
Johnson & Johnson Innovation JJDC, Inc. 7.11 2,449,183 71.88 13F 12/31/20
Farallon Capital Management LLC 7.04 2,425,000 71.17 Stakes 12/31/20
The Vanguard Group, Inc. 6.08 2,093,475 61.44 Funds 3/31/21
Vanguard Group, Inc. (Subfiler) 5.55 1,912,272 56.13 13F 12/31/20
BlackRock Fund Advisors 4.35 1,496,659 43.93 13F 12/31/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.